1. Patient Protection and Affordable Care Act. Section 2501(d). Enacted March 23, 2010. Pub. L. 111-148. Subsequently amended by the Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152, 2010) and Bipartisan Budget Act of 2018 (Pub. L. 115-123. 2018).
2. Federal Register. Proposed rule by the Centers for Medicare and Medicaid Services. Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements. 85 FR 37286. https://www.govinfo.gov/content/pkg/FR-2020-06-19/pdf/2020-12970.pdf. Accessed December 1, 2021.
3. Federal Register. Final rule by the Centers for Medicare and Medicaid Services. Medicaid Program; Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third Party Liability (TPL) Requirements. 85 FR 87000. https://www.govinfo.gov/content/pkg/FR-2020-12-31/pdf/2020-28567.pdf. Accessed December 1, 2021.
4. Centers for Medicare and Medicaid Services. Medicaid Drug Rebate Program. https://www.medicaid.gov/medicaid/prescription-drugs/medicaid-drug-rebate-program/index.html. Accessed December 1, 2021.
5. US Prescription Brand Net Pricing Data and Analysis. SSR Health website. https://www.ssrhealth.com. Accessed December 1, 2021.